Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Epizyme, Inc.

NASDAQ: EPZMHealthcare / Biotechnology / USA
6.74+0.29+4.50%Vol 346 4401Y Perf -48.98%
Dec 10th, 2018 15:13
BID6.74 ASK6.75
Open6.50 Previous Close6.45
Pre-Market- After-Trading6.45
 - -%  - -%
Target Price
19.56 
Analyst Rating
Strong Buy 1.44
Potencial %
189.78 
Finscreener Ranking
★★★★★ —    64.72
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
★★★★+     62.12
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)534 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
2.91 
Earnings Date
7th Nov 2018

Today's Price Range

6.306.79

 

52wk Range

6.3021.40

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Neutral
Performance
1 Month
-17.20%
3 Months
-36.45%
6 Months
-59.69%
1 Year
-48.98%
3 Years
-55.91%
5 Years
-71.97%

Quotes

Name / TickerPriceChg.Chg.%
EPZM6.740.29004.50
AAPL168.930.44000.26
GOOG1 038.752.17000.21
MSFT107.072.25002.15
XOM76.02-1.6200-2.09
WFC48.78-1.4800-2.94
JNJ144.90-0.5300-0.36
FB142.064.64003.38
GE6.87-0.1400-2.00
JPM101.07-2.2200-2.15
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
7.20
Current Ratio
7.50
Long Term Debt to Total Capital
0.00
Total Debt to Equity
0.00
Interest Coverage
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-1 176.30
EBITDA Margin
-1 166.20
Pre-tax Profit Margin
-1 606.20
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
3.42
PS Ratios
48.95
Price to Cash Flow
30.20
Price to Free Cash Flow
-4.50
Cash Flow Per Share
-1.86
Price to Tangible Book
3.42
Book Value per Share
2.17
Enterprise Value (in ths.)
406 713
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-60.92
ROE last 12 Months
-62.59
Return on Assets (5Y Avg)
-34.55
ROA last 12 Months
-52.59
Return on Capital (5Y Avg)
-51.21
ROC last 12 Months
-62.15
Return on invested Capital Q
-19.86
Return on invested Capital Y
-61.36
Assets Turnover
0.00
Receivables Turnover
1.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
12 000
Revenue per Share
0.15
Revenue Growth 3 Years
38.65
Revenue Growth 5 Years
-30.22
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.60-0.5410.00
Q02 2018-0.53-0.4220.75
Q01 2018-0.54-0.499.26
Q04 2017-0.56-0.527.14
Q03 2017-0.65-0.633.08
Q02 2017-0.56-0.4814.29
Q01 2017-0.63-0.5611.11
Q04 2016-0.64-0.606.25
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.5012.28Positive
12/2018 FY-1.937.21Positive
3/2019 QR-0.493.92Positive
12/2019 FY-2.21-6.25Negative
Next Report Date-
Estimated EPS Next Report-0.60
Estimates Count8
EPS Growth Next 5 Years %38.00
Volume Overview
Volume346 440
Shares Outstanding (in ths.)79 170
Trades Count1 990
Dollar Volume1 972 829
Avg. Volume495 790
Avg. Weekly Volume611 973
Avg. Monthly Volume558 578
Avg. Quarterly Volume649 580

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

29%71%

Bearish Bullish

64%36%

Bearish Bullish

74%26%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (77.78 %)
7 (77.78 %)
7 (70.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (22.22 %)
2 (22.22 %)
3 (30.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.44
Strong Buy
1.44
Moderate Buy
1.60

There are no comments yet.

News